PCN15 COST ANALYSIS BETWEEN TYROSINE KINASE INHIBITOR VERSUS DOCETAXEL IN ADVANCED NON-SMALL CELL LUNG CANCER
Abstract
Authors
N Topibulpong S Tanasanvimon N Parinyanitikul V Sriuranpong
N Topibulpong S Tanasanvimon N Parinyanitikul V Sriuranpong
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now